We understand how important it is for patients to have access to affordable insulin. That’s why we offer affordability solutions to help your diabetes patients get the treatment they need.
We understand how important it is for patients to have access to affordable insulin. That’s why we offer affordability solutions to help your diabetes patients get the treatment they need.
With this savings program, eligible patients may pay $35 for a monthly supply of any combination of Novo Nordisk insulin products, up to 3 vials or 2 packs of pens (up to 35 mL).a
If your patients have private or commercial insurance, they may be eligible to get savings on their Novo Nordisk insulin.
If your patients do not have insurance or are enrolled in a Medicare plan and need extra assistance, they may be able to get their insulin free of charge from Novo Nordisk. Novo Nordisk’s PAP is a no-cost program without any registration fees or monthly fees.
If patients are at risk of rationing their insulin and have an immediate need, we may be able to help with a one-time offer for a free, short-term supply of Novo Nordisk insulin (up to 3 vials or 2 packs of pens).b This offer is a short-term solution. We are committed to helping patients find a way to afford their insulin and encourage them to revisit the options above to meet their long-term needs.
Learn about human insulin options that may be more affordable, especially for those without insurance or with high-deductible health insurance plans. For your appropriate patients without insurance coverage, the cost could be as low as $25/vial through several national pharmacy programs.
Learn more about rapid-acting, premixed, and basal insulin Unbranded Biologics offered by Novo Nordisk Pharma, Inc. (NNPI). NNPI is a Novo Nordisk A/S company. This may be a more affordable option depending on a patient’s benefit design and formulary coverage. Out-of-pocket costs for an Unbranded Biologic may count toward your patients’ deductibles.